Loading the SOTA2 catalog…
Heartflow is a medical technology company that provides an AI-based platform to transform Coronary CTA (CCTA) scans into personalized 3D heart models for coronary artery disease diagnosis and treatment planning.
Customer voice
Quotes published on Heartflow, Inc.'s official website.
– Dr. Milind Parikh, Director of Preventive Cardiology and Cardiac CT at Image OneMeasurable Impact>650KPatients Treated>1,800Institutions Using Heartflow and Growing>625Peer-reviewed Publications99.5% of US Lives CoveredFeatured NewsHeartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention PlanningRead MoreHeartflow Plaque Analysis Now Supported by Scientific Statements From American College of Cardiology and American Heart Association for Personalized Management of Patients with Suspected CADRead MoreAHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk StratificationRead MoreDiscover how you can use Heartflow to advance your approach to coronary artery disease diagnosis, treatment and management. Contact Us1. Arbab-Zadeh, Armin.
I think Coronary CTA with Heartflow One is the future of cardiology. It helps us understand the disease from whether you have non-obstructive or a low, mild disease to a severe disease that actually needs intervention.
Contact Heartflow, Inc. for current plans, volume pricing, and enterprise terms.
Trust profile